Skip to main content

Hutton Scott's Form 4 filing

Biodesix Inc (BDSX) · filed May 10, 2023

Accession no.
0001140361-23-023966
Filed
May 10, 2023
Trade date
May 8-10, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $21.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hutton ScottCIK 0001697361Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 8, 2023Common StockMOption exerciseAcquired+44,778––254,504Direct
May 9, 2023Common StockSSaleDisposed−9,934$1.57−$15,596.38244,570Direct
May 10, 2023Common StockSSaleDisposed−3,848$1.58−$6,079.84240,722Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 8, 2023Common StockMOption exerciseDisposed−12,212$0.00$0134,332Direct
May 8, 2023Common StockMOption exerciseDisposed−32,566$0.00$032,565Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)